We are live on ! Find out more
NGNE icon

Neurogene
NGNE

55 hedge funds and large institutions have $241M invested in Neurogene in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

349% more capital invested

Capital invested by funds: $53.7M → $241M (+$188M)

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

53% more funds holding

Funds holding: 36 → 55 (+19)

23% more call options, than puts

Call options by funds: $777K | Put options by funds: $632K

1.33% less ownership

Funds ownership: 3.35% → 2.01% (-1.3%)

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

Holders
55
Holders Change
+19
Holders Change %
+52.78%
% of All Funds
1.08%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
29
Increased
9
Reduced
13
Closed
10
Calls
$777K
Puts
$632K
Net Calls
+$145K
Net Calls Change
+$144K

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$9.57M
2
EC
EcoR1 Capital
California
+$8.22M
3
BC
Boxer Capital
California
+$5.03M
4
O
OrbiMed
New York
+$4.48M
5
PA
Perceptive Advisors
New York
+$2.49M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$39.4M
2
Millennium Management
Millennium Management
New York
-$1.8M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.15M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$657K
5
Two Sigma Investments
Two Sigma Investments
New York
-$262K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$48.2M +$8.22M +82,500 +73%
BBA
2
Baker Bros. Advisors
New York
$41.9M -$39.4M -395,397 -70%
RG
3
Redmile Group
California
$23.7M +$9.57M +96,042 New
OM
4
Opaleye Management
Massachusetts
$17M +$1.92M +19,315 +39%
BC
5
Boxer Capital
California
$12.4M +$5.03M +50,463 New
O
6
OrbiMed
New York
$11.1M +$4.48M +45,000 New
FFM
7
Fairmount Funds Management
Pennsylvania
$9.98M +$4.03M +40,504 New
Renaissance Technologies
8
Renaissance Technologies
New York
$8.86M -$241K -2,423 -6%
BlackRock
9
BlackRock
New York
$7.47M +$1.48M +14,831 +96%
Vanguard Group
10
Vanguard Group
Pennsylvania
$6.43M +$1.38M +13,823 +113%
PA
11
Perceptive Advisors
New York
$6.16M +$2.49M +25,000 New
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$5.88M -$657K -6,596 -22%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$5.42M +$216K +2,169 +11%
SFM
14
Sphera Funds Management
Israel
$4.68M +$1.89M +19,000 New
ACP
15
Acuta Capital Partners
California
$4.59M +$1.86M +18,625 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.35M +$506K +5,079 +60%
APM
17
Avidity Partners Management
Texas
$2.59M +$1.05M +10,500 New
Alkeon Capital Management
18
Alkeon Capital Management
New York
$2.46M +$996K +10,000 New
RA
19
Royce & Associates
New York
$1.79M – – –
PVI
20
Pura Vida Investments
New York
$1.58M +$638K +6,409 New
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$1.56M +$631K +6,339 New
ECM
22
ExodusPoint Capital Management
New York
$1.54M +$624K +6,261 New
BCM
23
Bridgeway Capital Management
Texas
$1.48M -$49.8K -500 -8%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$1.24M +$502K +5,037 New
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$1.13M -$128K -1,282 -22%
1
2 3

NGNE Hedge Fund Activity: Q4 2019 in Review

55 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2019, worth a combined $241M — up 349% from $53.7M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new NGNE positions and 10 closed out — a net gain of 19 holders — while 9 added to existing stakes and 13 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $9.57M. The largest seller was Baker Bros. Advisors, cutting an estimated $39.4M.

  • 55 institutional investors held Neurogene (NGNE) as of Q4 2019, up from 36 in Q3 2019.
  • Funds reported $241M of Neurogene stock for Q4 2019, up 349% quarter-over-quarter.
  • 29 funds opened new Neurogene positions in Q4 2019 and 10 closed out, a net change of +19 holders.
  • The largest Neurogene buyer in Q4 2019 was Redmile Group, an estimated $9.57M added.
  • The largest Neurogene seller in Q4 2019 was Baker Bros. Advisors, an estimated $39.4M sold.

Based on aggregated 13F filings for Q4 2019.